Cell Cryopreservation Market-By Product Type (Cryoprotectant Agents, Equipment), Cell Type (Stem Cells, Oocytes & Embryotic Cells, Sperm Cells), Application (Drug Discovery & Development, Regenerative Medicine), End-use-Global Forecast, 2024-2032

Description

Global Cell Cryopreservation Market will register a 21.5% CAGR from 2024 to 2032 due to advancements in biobanking technologies and the expanding applications of stem cell research. With the launch of new laboratories, there's an increased capacity for cryopreserving cells for various purposes, such as regenerative medicine, drug discovery, and tissue engineering. These developments offer opportunities for preserving valuable cell resources, driving demand. Additionally, the growing emphasis on personalized medicine and the rising adoption of stem cell-based therapies will further contribute to the market expansion.

For instance, in October 2023, OrganaBio, a contract technology development and manufacturing organization (CTDMO) focusing on cell and immunotherapy solutions, introduced a new division called Cell Processing and Cryopreservation (CPC) Services. This specialized division aims to offer decentralized clinical trial support, encompassing prompt sample processing and data capture tailored to the needs of the industry.

The cell cryopreservation market is classified based on cell type, application, and region.

The oocytes and embryotic cells segment will capture a remarkable share by 2032, driven by the increasing demand for assisted reproductive technologies (ART) and fertility preservation procedures. Oocytes and embryotic cells are crucial for in vitro fertilization (IVF) procedures and stem cell research, prompting higher adoption rates. Moreover, advancements in cryopreservation techniques have improved the viability and success rates of storing these cells, further fueling the growth of this segment in the market.

The regenerative medicine segment will achieve notable market share by 2032, fueled by the increasing applications of cryopreserved cells in regenerative therapies, tissue engineering, and stem cell research. Additionally, advancements in cryopreservation techniques, in line with growing investments in regenerative medicine research, bolster the segment's growth. With regenerative medicine emerging as a promising field for treating various medical conditions, the demand for cryopreserved cells will surge, solidifying the segment's leading position in the market.

Asia Pacific cell cryopreservation industry will demonstrate a significant CAGR from 2024 to 2032, attributed to several factors, including the increasing prevalence of chronic diseases, rising healthcare expenditure, and growing awareness about the benefits of stem cell therapy. Moreover, the region's expanding biotechnology and pharmaceutical industries, in tandem with supportive government initiatives, will contribute to market growth. With a large population base and improving healthcare infrastructure, Asia Pacific will maintain its prominence in the cell cryopreservation market.

Product Code: 7882

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Base estimates and workings
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global cell cryopreservation market 360 degree synopsis, 2018 - 2032
- 2.1.1 Regional trends
- 2.1.2 Product type trends
- 2.1.3 Cell type trends
- 2.1.4 Application trends
- 2.1.5 End-use trends

Chapter 3 Cell Cryopreservation Industry Insights

3.1 Industry ecosystem analysis
3.2 Technology landscape
3.3 Regulatory landscape
3.4 Industry impact forces
- 3.4.1 Growth drivers
  - 3.4.1.1 Rising stem cell research
  - 3.4.1.2 Increasing organ transplantation procedures
  - 3.4.1.3 Growing trend towards personalized medicine
  - 3.4.1.4 Increasing biobanking activities
- 3.4.2 Industry pitfalls and challenges
  - 3.4.2.1 High cost of cryopreservation technologies
  - 3.4.2.2 Ethical and regulatory challenges
3.5 Growth potential analysis
- 3.5.1 By product type
- 3.5.2 By cell type
- 3.5.3 By application
- 3.5.4 By end-use
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic outlook matrix, 2023

Chapter 5 Cell Cryopreservation Market Size and Forecast, By Product Type, 2018-2032 (USD Million)

5.1 Key trends, by product type
5.2 Cryoprotectant agents
- 5.2.1 Dimethyl sulfoxide (DMSO)
- 5.2.2 Ethylene glycol
- 5.2.3 Glycerol
- 5.2.4 Other agents
5.3 Equipment
- 5.3.1 Freezers
- 5.3.2 Incubators
- 5.3.3 Liquid nitrogen supply tanks
- 5.3.4 Cryopreservation consumables

Chapter 6 Cell Cryopreservation Market Size and Forecast, By Cell Type, 2018-2032 (USD Million)

6.1 Key trends, by cell type
6.2 Stem cells
6.3 Oocytes and embryotic cells
6.4 Sperm cells
6.5 Hepatocytes
6.6 Other cell types

Chapter 7 Cell Cryopreservation Market Size and Forecast, By Application, 2018-2032 (USD Million)

7.1 Key trends, by application
7.2 Drug discovery and development
7.3 Regenerative medicine
7.4 Organ transplantation
7.5 Clinical research
7.6 Other applications

Chapter 8 Cell Cryopreservation Market Size and Forecast, By End-use, 2018-2032 (USD Million)

8.1 Key trends, by end-use
8.2 Hospitals and clinics
8.3 Biotechnology and pharmaceutical companies
8.4 Research and academic institutes
8.5 Contract research organizations (CROs)

Chapter 9 Cell Cryopreservation Market Size and Forecast, By Region, 2018-2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 Thermo Fisher Scientific Inc.
10.2 Sartorius AG
10.3 PromoCell GmbH
10.4 BioLife Solutions Inc.
10.5 Merck KGaA
10.6 HiMedia Laboratories
10.7 Creative Biolabs
10.8 Corning Incorporated
10.9 GE Healthcare
10.10 Danaher Corporation